Cubist Systematic Strategies’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-331
Closed -$5.86K 4008
2023
Q3
$5.86K Buy
+331
New +$12.1K ﹤0.01% 3166
2023
Q2
Sell
-377
Closed -$25.7K 4168
2023
Q1
$25.7K Sell
377
-200
-35% -$15.6K ﹤0.01% 3649
2022
Q4
$34.9K Buy
+577
New +$53.6K ﹤0.01% 3945
2022
Q3
Sell
-2,050
Closed -$181K 4670
2022
Q2
$181K Buy
2,050
+141
+7% +$17.2K ﹤0.01% 3754
2022
Q1
$290K Sell
1,909
-434
-19% -$80.7K ﹤0.01% 2862
2021
Q4
$747K Buy
+2,343
New +$826K 0.01% 2148

Other funds holding RBOT

Cubist Systematic Strategies's RBOT Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of Vicarious Surgical (RBOT) in Q4 2023, closing a stake of 331 shares — an estimated $5.86K sold.

Cubist Systematic Strategies first reported a position in RBOT in Q4 2021 and held it in 6 quarters. The position peaked at $747K in Q4 2021. 72 funds tracked by Wall St. Rank hold RBOT as of Q4 2023.

  • Cubist Systematic Strategies reported no remaining Vicarious Surgical position as of Q4 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 331 Vicarious Surgical shares in Q4 2023, an estimated $5.86K.
  • Cubist Systematic Strategies first reported a position in Vicarious Surgical in Q4 2021 and held it in 6 quarters.
  • Cubist Systematic Strategies's Vicarious Surgical position peaked at $747K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.